Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Altimmune (ALT) over the last 10 years, with Q3 2025 value amounting to $1.1 million.

  • Altimmune's Non-cash Items fell 7413.46% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 7413.46%. This contributed to the annual value of $3.7 million for FY2024, which is 5109.39% up from last year.
  • According to the latest figures from Q3 2025, Altimmune's Non-cash Items is $1.1 million, which was down 7413.46% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Altimmune's Non-cash Items ranged from a high of $25.7 million in Q4 2022 and a low of $16975.0 during Q3 2022
  • In the last 5 years, Altimmune's Non-cash Items had a median value of $2.5 million in 2025 and averaged $5.8 million.
  • In the last 5 years, Altimmune's Non-cash Items plummeted by 9827.6% in 2022 and then soared by 5070012.13% in 2024.
  • Quarter analysis of 5 years shows Altimmune's Non-cash Items stood at $8.5 million in 2021, then skyrocketed by 204.07% to $25.7 million in 2022, then plummeted by 34.23% to $16.9 million in 2023, then tumbled by 78.2% to $3.7 million in 2024, then tumbled by 70.83% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $4.3 million for Q2 2025, and $2.5 million during Q1 2025.